ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2461
0,00%
Bitcoin
69.191,02
2,13%
Brent Oil
81,245
0,54%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. SciSparc Ltd (SPRC)

  7. SciSparc Ltd (SPRC) Notícias

SPRC SciSparc Ltd

0,9301
0,0001 (0,01%)
Pré-mercado
Última atualização: 08:00:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
SciSparc Ltd SPRC NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,0001 0,01% 0,9301 08:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,93
mais cotações »

Notícias Recentes

Data Hora Fonte Título
31/05/202408:17GLOBESciSparc Secures Strategic Advantage with Grant of European..
11/04/202409:15GLOBESciSparc to Acquire AutoMax
21/03/202409:58GLOBESciSparc: MitoCareX Unveils Groundbreaking Discovery of..
18/03/202408:29GLOBESciSparc Granted Another Patent, Strengthening its Core..
14/03/202409:49GLOBESciSparc Achieves Major Milestone with First Patient Dosed..
12/03/202409:14GLOBESciSparc: MitoCareX Reveals Promising Results with Discovery..
08/03/202409:11GLOBESciSparc Announces Enrollment of First Patient for its..
07/03/202409:49GLOBESciSparc Granted Patent for Core Technology in Multiple..
06/03/202418:41GLOBESciSparc Issued Canadian Patent for Opioids Reduction Use in..
29/02/202410:35GLOBESciSparc Delivers Treatment for Autism Spectrum Disorder..
27/02/202409:58GLOBESciSparc-Clearmind Partnership Yields Three New..
20/02/202409:14GLOBEClearmind Medicine Submits Three International Patent..
29/01/202409:18GLOBESciSparc Announces Initiation of Patient Recruitment for its..
24/01/202409:42GLOBESciSparc Ltd. Announces $20 Million Standby Equity Purchase..
19/01/202411:28GLOBESciSparc Advances the Acquisition Process of a Leading..
04/01/202409:18GLOBESciSparc and Clearmind Medicine Reflect on Successful..
13/12/202310:18GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
07/12/202311:05GLOBESciSparc Provides Updates Regarding the Non-Binding Letter..
01/12/202310:14GLOBEWeight Loss Treatment: SciSparc’s Obesity Drug Showed..
28/11/202310:55GLOBESciSparc Adopts Limited Duration Shareholder Rights Plan
28/11/202310:25GLOBESciSparc Announces Positive Results from its Weight Loss and..
27/11/202310:41GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
24/11/202310:55GLOBENew Hope for Children: SciSparc's patented CBD- Enhanced..
22/11/202309:42GLOBESciSparc Signs Non-Binding Letter of Intent to Merge with..
15/11/202310:01GLOBESciSparc Celebrates Major Breakthrough: Positive Results..
10/11/202311:10GLOBESciSparc Aims to Change Tourette Syndrome Treatments; Will..
31/10/202308:38GLOBESciSparc Granted Patent from the Australian Patent Office..
24/10/202308:20GLOBESciSparc Granted Patent for its Core Technology From the..
16/10/202309:17GLOBESciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid..
13/10/202317:28GLOBESciSparc Ltd. Announces Closing of $5.026 Million Private..
11/10/202310:15GLOBESciSparc Ltd. Announces Pricing of $5.026 Million Private..
03/10/202308:33GLOBESciSparc Granted European Patent for its Core Technology
29/09/202308:45GLOBESciSparc Initiated Its Clinical Trial with SCI-210 in..
27/09/202310:49IHNWSciSparc Announces Expected Implementation of 1-for-26..
27/09/202308:58GLOBESciSparc Announces Expected Implementation of 1-for-26..
20/09/202307:30GLOBESciSparc Announces 1-for-26 Reverse Share Split
12/09/202310:15GLOBESciSparc Engages Investment Bank to Identify Potential..
07/09/202310:15GLOBESciSparc Announces Initiation of Randomized Phase IIb..
07/09/202307:00GLOBESciSparc Granted 180-Day Extension by Nasdaq to Regain..
14/08/202313:20GLOBESciSparc Ltd. Closes $1.3 Million Underwritten Public..
10/08/202310:10GLOBESciSparc Ltd. Announces Pricing of $1.3 Million Underwritten..
09/08/202317:40GLOBESciSparc Ltd. Announces Proposed Underwritten Public..
01/08/202310:00GLOBESciSparc and Clearmind Collaboration Continues to Increase..
14/07/202308:55GLOBESciSparc to Commence Its Clinical Trial with SCI-210 in..
30/06/202310:25GLOBESciSparc Receives Approval to Conduct Phase IIb Clinical..
21/06/202310:00GLOBESciSparc Announces IRB Approval to Conduct its Phase IIb..
16/06/202310:05GLOBESciSparc and Clearmind Medicine to Conduct a Study..
07/06/202309:05GLOBESciSparc Grants an Exclusive License for the Sales of..

Seu Histórico Recente

NASDAQ
SPRC
SciSparc
COIN
MBRSETH
DBI
LZM4
DAXglobal Asia Technolog...
XE
BFSA
Befesa
BIT
TKA
Thyssenkrupp
BIT
PRY
Prysmian
BIT
W946M0
UBS
BIT
I07249
INTESA SANPAOLO
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados